{"id":5273,"date":"2021-11-30T15:36:42","date_gmt":"2021-11-30T12:36:42","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=5273"},"modified":"2021-12-01T15:48:35","modified_gmt":"2021-12-01T12:48:35","slug":"merckin-oral-covid-ilacina-acil-kullanim-izni-tavsiyesi-icin-yapilan-oylamada-karar-ucu-ucuna-cikti","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/merckin-oral-covid-ilacina-acil-kullanim-izni-tavsiyesi-icin-yapilan-oylamada-karar-ucu-ucuna-cikti\/","title":{"rendered":"FDA Dan\u0131\u015fma Panelinde, Merck&#8217;in COVID \u0130lac\u0131na Acil Kullan\u0131m \u0130\u00e7in Tavsiye Karar\u0131 K\u0131l Pay\u0131 \u00c7\u0131kt\u0131"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-108080 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2021\/12\/News.png\" alt=\"\" width=\"119\" height=\"40\" \/><strong>ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA) taraf\u0131ndan Sal\u0131 g\u00fcn\u00fc d\u00fczenlenen dan\u0131\u015fma paneli, Merck&#8217;in COVID-19&#8217;u tedavi etmek i\u00e7in geli\u015ftirdi\u011fi deneysel oral antiviraline acil kullan\u0131m izni tavsiyesi i\u00e7in oylama yapt\u0131 ve kurumun hastal\u0131\u011fa y\u00f6nelik ilk oral ilac\u0131 onaylamas\u0131n\u0131n yolunu a\u00e7t\u0131. Komite, karar\u0131 &#8220;zor&#8221; olarak nitelendirerek, 13-10 ilac\u0131n lehinde oy verdi.<\/strong><\/p>\n<p>Kurumun Antimikrobiyal \u0130la\u00e7lar Dan\u0131\u015fma Komitesi (AMDAC) \u00fcyeleri, a\u011f\u0131r hastal\u0131k veya hastaneye yat\u0131\u015f riski ta\u015f\u0131yan hafif ve orta dereceli COVID-19&#8217;lu yeti\u015fkinlerde kullan\u0131lmak \u00fczere geli\u015ftirilen molnupiravir i\u00e7in 13-10 lehte oy kulland\u0131.<\/p>\n<p>G\u00fcn boyu s\u00fcren halka a\u00e7\u0131k toplant\u0131 s\u0131ras\u0131nda, komite \u00fcyeleri \u00e7ok say\u0131da soru y\u00f6nelttiler; Merck ve Ridgeback Biotherapeutics taraf\u0131ndan geli\u015ftirilen ilac\u0131n g\u00fcvenli\u011fi ve etkinli\u011fi konusunda endi\u015felerini dile getirdiler ve sonu\u00e7ta lehte oy kulland\u0131lar.<\/p>\n<p>AMDAC ba\u015fkan\u0131 Dr. Lindsey Baden, oylaman\u0131n ard\u0131ndan, ilac\u0131n yararlar\u0131 ile risklerini de\u011ferlendirirken komite \u00fcyelerinin \u00e7o\u011funun arada kald\u0131klar\u0131n\u0131 s\u00f6yledi.<\/p>\n<p>Baden, lehte oy verenlerin, ilac\u0131n etkinli\u011finin &#8220;de\u011ferlendirilmesi gereken sorunlara ra\u011fmen g\u00f6r\u00fcn\u00fcr&#8221; oldu\u011funu d\u00fc\u015f\u00fcnd\u00fcklerini s\u00f6yledi. Tavsiyeye kar\u015f\u0131 oy verenlerin ise \u00f6zetle, verilere ikna olmad\u0131klar\u0131n\u0131 ve fet\u00fcslere zarar verme olas\u0131l\u0131\u011f\u0131 ve DNA hasar\u0131 dahil olmak \u00fczere potansiyel risklerle ilgili endi\u015felerini dile getirdiklerini ifade etti.<\/p>\n<p><a href=\"https:\/\/www.nbcnews.com\/health\/health-news\/fda-advisory-panel-recommends-mercks-covid-pill-emergency-use-rcna7107\"><strong>Haber \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ABD G\u0131da ve \u0130la\u00e7 \u0130daresi (FDA) taraf\u0131ndan Sal\u0131 g\u00fcn\u00fc d\u00fczenlenen dan\u0131\u015fma paneli, Merck&#8217;in COVID-19&#8217;u tedavi etmek i\u00e7in geli\u015ftirdi\u011fi deneysel oral antiviraline acil kullan\u0131m izni tavsiyesi i\u00e7in oylama yapt\u0131 ve kurumun hastal\u0131\u011fa y\u00f6nelik ilk oral ilac\u0131 onaylamas\u0131n\u0131n yolunu a\u00e7t\u0131. Komite, karar\u0131 &#8220;zor&#8221; olarak nitelendirerek, 13-10 ilac\u0131n lehinde oy verdi. Kurumun Antimikrobiyal \u0130la\u00e7lar Dan\u0131\u015fma Komitesi (AMDAC) \u00fcyeleri, a\u011f\u0131r hastal\u0131k veya hastaneye yat\u0131\u015f riski ta\u015f\u0131yan hafif ve orta dereceli COVID-19&#8217;lu yeti\u015fkinlerde kullan\u0131lmak \u00fczere geli\u015ftirilen molnupiravir i\u00e7in 13-10 lehte oy kulland\u0131. G\u00fcn boyu s\u00fcren halka a\u00e7\u0131k toplant\u0131 s\u0131ras\u0131nda, komite \u00fcyeleri \u00e7ok say\u0131da soru y\u00f6nelttiler; Merck ve Ridgeback Biotherapeutics taraf\u0131ndan geli\u015ftirilen ilac\u0131n g\u00fcvenli\u011fi ve etkinli\u011fi [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5274,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5273"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=5273"}],"version-history":[{"count":3,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5273\/revisions"}],"predecessor-version":[{"id":5277,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5273\/revisions\/5277"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/5274"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=5273"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=5273"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=5273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}